The regulator's worries center on the fund's liquidity, its name and its ability to comply with valuation rules.

Good afternoon, and welcome to Castle Biosciences fourth quarter and full year 2024 conference call. As a reminder, today's call is being recorded. We will begin today's call with opening remarks and ...

Good afternoon, and welcome to Alignment Healthcare's fourth-quarter 2024 earnings conference call and webcast. (Operator Instructions) Please note that this event is being recorded. Leading today's ...

The bond market is jittery. A higher-for-longer environment for interest rates is persisting. A recent US government-bond selloff rippled across the world. None of this is making bond investors happy.